- Home
- LGCL vs ESLA Comparison
LGCL vs ESLA Comparison
Compare LGCL & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- ESLA
- Stock Information
- Founded
- LGCL 2009
- ESLA 2021
- Country
- LGCL China
- ESLA United States
- Employees
- LGCL N/A
- ESLA N/A
- Industry
- LGCL
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGCL
- ESLA Health Care
- Exchange
- LGCL NYSE
- ESLA Nasdaq
- Market Cap
- LGCL 44.3M
- ESLA 41.6M
- IPO Year
- LGCL 2024
- ESLA N/A
- Fundamental
- Price
- LGCL $0.48
- ESLA $1.16
- Analyst Decision
- LGCL
- ESLA
- Analyst Count
- LGCL 0
- ESLA 0
- Target Price
- LGCL N/A
- ESLA N/A
- AVG Volume (30 Days)
- LGCL 401.3K
- ESLA 58.4K
- Earning Date
- LGCL 11-22-2024
- ESLA 02-12-2025
- Dividend Yield
- LGCL N/A
- ESLA N/A
- EPS Growth
- LGCL 11.49
- ESLA N/A
- EPS
- LGCL 0.14
- ESLA N/A
- Revenue
- LGCL $173,306,912.00
- ESLA N/A
- Revenue This Year
- LGCL N/A
- ESLA N/A
- Revenue Next Year
- LGCL N/A
- ESLA N/A
- P/E Ratio
- LGCL $3.52
- ESLA N/A
- Revenue Growth
- LGCL N/A
- ESLA N/A
- 52 Week Low
- LGCL $0.47
- ESLA $0.63
- 52 Week High
- LGCL $5.00
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- ESLA 52.28
- Support Level
- LGCL N/A
- ESLA $1.02
- Resistance Level
- LGCL N/A
- ESLA $1.41
- Average True Range (ATR)
- LGCL 0.00
- ESLA 0.23
- MACD
- LGCL 0.00
- ESLA -0.02
- Stochastic Oscillator
- LGCL 0.00
- ESLA 30.11
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.